| J9271 | Injection, pembrolizumab, 1 mg | 10,300 | $40 | $442.9K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 8,820 | $40 | $335.2K |
| J0897 | Injection, denosumab, 1 mg | 2,580 | $20 | $46.4K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,840 | $20 | $40.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 250 | $120 | $30.1K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 120 | $160 | $18.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 120 | $110 | $12.6K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 90 | $130 | $11.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 130 | $80 | $10.4K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 150 | $70 | $10.1K |